logo

Spark Therapeutics (ONCE)



Trade ONCE now with
  Date
  Headline
1/16/2018 6:42:21 AM Wedbush Lowers Spark Therapeutics (ONCE) To Underperform From Neutral With $35 Down From $50 Price Target
1/7/2018 9:50:22 AM New Drugs Approved In December
1/4/2018 7:34:27 AM Spark Therapeutics Announces Addition Of Robert Perez To Board Of Directors
1/3/2018 8:36:06 AM Spark Therapeutics Announces First-of-their-kind Programs To Improve Patient Access To LUXTURNA
12/19/2017 3:51:31 PM Wedbush Reiterates Spark Therapeutics (ONCE) At Neutral With $50 Price Target
12/19/2017 11:38:31 AM Spark: FDA Approves Blindness Gene Therapy
12/12/2017 11:58:09 AM Wedbush Is Raising Spark Therapeutics (ONCE) FY18 Rev. Estimate To 32.2 M From 27.3 M
12/12/2017 11:57:26 AM Wedbush Is Increasing Spark Therapeutics (ONCE) Q4 18 Rev. Estimate To 12.5 M From 11.5 M
12/12/2017 11:56:53 AM Wedbush Is Raising Spark Therapeutics (ONCE) Q3 18 Rev. Estimate To 9.2 M From 7.4 M
12/12/2017 11:56:23 AM Wedbush Is Raising Spark Therapeutics (ONCE) Q2 18 Rev. Estimate To 7.0 M From 5.5 M
12/12/2017 11:55:33 AM Wedbush Is Raising Spark Therapeutics (ONCE) Q1 18 Rev. Estimate To 3.6 M From 2.8 M
12/12/2017 11:54:22 AM Wedbush Is Raising Spark Therapeutics (ONCE) FY18 Estimate To -6.99 From -7.65
12/12/2017 11:53:28 AM Wedbush Is Raising Spark Therapeutics (ONCE) Q4 18 Estimate To -1.69 From -1.85
12/12/2017 11:52:19 AM Wedbush Is Increasing Spark Therapeutics (ONCE) Q3 18 Estimate To -1.74 From -1.91
12/12/2017 11:43:56 AM Wedbush Is Raising Spark Therapeutics (ONCE) Q2 18 Estimate To -1.76 From -1.93
12/12/2017 11:42:54 AM Wedbush Is Increasing Spark Therapeutics (ONCE) Q1 18 Estimate To -1.80 From -1.96
12/12/2017 11:42:13 AM Wedbush Is Raising Spark Therapeutics (ONCE) FY17 Estimate To -7.72 From -7.84